I do think there is a debate about weather Viking can make VK2735 at scale competitively cause its a peptide large molecule. I'm going to repeat my earlier investment thesis on this point which is basically Brian Lian is not an idiot. He has a PhD in Organic Chemistry,, has a great business sense and would not waste resources on something that wasn't going to be competitive. ( He's also got 930 Million in the bank.)
It is a good problem to have, expecting high demand so having some raise questions as to whether you can meet that demand. Obviously VK2735 still needs to complete phase 3 for sc delivery and phase 2 & 3 for oral but I can wait.
Vin & Marthambles- Yes I did expect volatility today but not this extreme.
Extreme is the word, going from over $90 in pre-market to $64 is really impressive. Volume is really impressive too with over 26 million shares traded so far or 9x the usual volume. Nobody said biotech investing was for the faint of heart.
If the stock price drops into the $50s I will buy more.